Precigen, Inc
Clinical trials sponsored by Precigen, Inc, explained in plain language.
-
Second chance treatment tested for rare throat growths
Disease control Recruiting nowThis study is testing whether a second round of treatment with an experimental therapy called zopapogene imadenovec (Zopa) can help adults with recurrent respiratory papillomatosis (RRP), a condition causing wart-like growths in the throat and airways. Researchers will track how …
Phase: PHASE4 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for advanced cervical cancer: trial tests drug combo after standard treatment fails
Disease control Recruiting nowThis study is for people with advanced cervical cancer that has returned or spread and is no longer responding to the immunotherapy drug pembrolizumab. It will test if adding a new investigational drug called PRGN-2009 to pembrolizumab is more effective and safe than continuing p…
Phase: PHASE2 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC